Skip to main content

Advertisement

Log in

Infection mitigation a necessity in lupus patients

  • Letter to the Editor
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Jakes RW, Bae S-C, Louthrenoo W, Mok CC, Navarra SV, Kwon N (2012) Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res (Hoboken) 64:159–168. https://doi.org/10.1002/acr.20683

    Article  Google Scholar 

  2. Teh CL, Wan SA, Ling GR (2018) Severe infections in systemic lupus erythematosus: disease pattern and predictors of infection-related mortality. Clin Rheumatol 37:2081–2086. https://doi.org/10.1007/s10067-018-4102-6

    Article  PubMed  CAS  Google Scholar 

  3. Liu P, Tan HZ, Li H, Lim CC, Choo JCJ (2018) Infections in hospitalized lupus nephritis patients: characteristics, risk factors, and outcomes. Lupus 27:1150–1158. https://doi.org/10.1177/0961203318768881

    Article  PubMed  CAS  Google Scholar 

  4. Yap DYH, Tang CSO, Ma MKM, Lam MF, Chan TM (2012) Survival analysis and causes of mortality in patients with lupus nephritis. Nephrol Dial Transplant 27:3248–3254. https://doi.org/10.1093/ndt/gfs073

    Article  PubMed  Google Scholar 

  5. Feldman CH, Hiraki LT, Winkelmayer WC et al (2015) Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis. Arthritis Rheumatol (Hoboken, NJ) 67:1577–1585. https://doi.org/10.1002/art.39070

    Article  Google Scholar 

  6. Tecklenborg J, Clayton D, Siebert S, Coley SM (2018) The role of the immune system in kidney disease. Clin Exp Immunol 192:142–150. https://doi.org/10.1111/cei.13119

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  7. Lightstone L, Doria A, Wilson H, Ward FL, Larosa M, Bargman JM (2018) Can we manage lupus nephritis without chronic corticosteroids administration? Autoimmun Rev 17:4–10. https://doi.org/10.1016/j.autrev.2017.11.002

    Article  PubMed  CAS  Google Scholar 

  8. Condon MB, Ashby D, Pepper RJ, Cook HT, Levy JB, Griffith M, Cairns TD, Lightstone L (2013) Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids. Ann Rheum Dis 72:1280–1286. https://doi.org/10.1136/annrheumdis-2012-202844

    Article  PubMed  CAS  Google Scholar 

  9. Kamen DL (2009) How can we reduce the risk of serious infection for patients with systemic lupus erythematosus? Arthritis Res Ther 11:129. https://doi.org/10.1186/ar2818

    Article  PubMed  PubMed Central  Google Scholar 

  10. Lim CC, Tung YT, Tan BH, Lee PH, Mok I, Oon L, Chan KP, Choo JCJ (2018) Epidemiology and risk factors for cytomegalovirus infection in glomerular diseases treated with immunosuppressive therapy. Nephrology 23:676–681. https://doi.org/10.1111/nep.13071

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peiyun Liu.

Ethics declarations

Disclosures

Jason Choo has served on Advisory Boards for Novartis and Pfizer with donation of honorarium to Singapore General Hospital to support research and education.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, P., Tan, H.Z., Li, H. et al. Infection mitigation a necessity in lupus patients. Clin Rheumatol 38, 261–262 (2019). https://doi.org/10.1007/s10067-018-4346-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-018-4346-1

Navigation